1. Home
  2. Company search

Company search

KOBE Life Science Cluster Company List

Business Expansion
on Kobe's Port Island

360

companies

as of November 30, 2022

Companies are divided into each categories by their major business field on Kobe Port Island. In the case they have other business fields, it is shown in the miner field.» List of KBIC companies(PDF)

≫ StartupsStartups Company List

Search by Company name or Keyword

Business sector search results

110of Results 12

Re-search in Business sector
  1. 1
  2. 2
  3. >

Location search results

110of Results 12

Re-search in Location
  1. 1
  2. 2
  3. >

You can select the initial.

Initial search resultsO

110of Results 12

Re-search in Initial
  1. 1
  2. 2
  3. >

OKLEX Co. Ltd.

Major field:Material and Chemical Products

Miner field:Production of Research Equipment

Production and sales of super shields for medical X-ray machines and cover screens

Okura Industrial Co.,Ltd.

Major field:Material and Chemical Products

Design and development of medical devices through the use of functional films and other materials

Overview

Providing processing technologies and functional films for packaging, industrial use, optical film for FPD, wood building materials, etc.

Product / Service / PR

    [Strong point of Okura]
    Processing technologies obtained the production of plastic film used as functional materials and product lineups in the wide ranges of fields.
    ・Various kinds of products based on polyethylene and polypropylene used in many applications such as food packaging, industrial materials, etc.
    ・Urethane film for the automotive industry, clothes, healthcare.
    ・Optical and functional film in the field of electronic information.
Address: 1515 Nakazu-cho, Marugame, Kagawa 763-8508 Japan  (Contact Person JUNPEI YUGICHI (R&D Center))
TEL: +81-877-56-1260 FAX: +81-877-56-1263
Web site: http://www.okr-ind.co.jp E-mail: j-yuguchi@okr-ind.co.jp

OMRON Corporation

Major field:Other

Oncolys BioPharma Inc.

Major field:Drug Discovery

Miner field:Production of Drugs and Quasi Drugs

Miner field:Diagnostic Agent and Device

R&D of medicine

Overview

Unique drug discovery and development standing on virology.
We do our business activities of pharmaceutical and diagnostic businesses together under the concept of "drug discovery and development standing on virology".
In pharmaceutical business, we will develop safe, effective and novel drug targeting "cancer and serious infectious diseases" that can be a new option of therapy for such intractable diseases. In diagnostic business, we will provide new inspection services using genetic modification technology for virus that is our platform technology. We will establish multiple earning structures based on the achievement by the activities above, and accelerate the development of current new drug candidates under more stable management environment. In addition, we will actively seek or obtain seeds for new drugs to continue and expand our business for the future.

Product / Service / PR

    TelomeScan is a gene-modified virus for detecting cancer cell. The insertion into the virus of a green fluorescent protein (GFP) gene from jellyfish causes cancer cells to emit green fluorescent light as the virus replicates within them, enabling sensitive detection of circulating tumor cells (CTC) which detach from the tumor and circulate within the blood. We focus on especially the detection of CTCs in lung cancer that was difficult to efficiently detect using the conventional technologies and the detection of CTCs on prostate cancer and breast cancer. In these areas, increase in the number of patients is predicted. Oncolys BioPharma provides services not only reporting the number of CTCs in blood but also analyzing the grade of malignancy (T-CAS: TelomeScan CTC Analysis System), and it is expected that such services allow prediction of prognosis and the selection of appropriate treatments of cancer patients. It is further expected that Telome Scan realizes gene analysis services using CTCs (T-GEN: TelomeScan Genotyping System) and facilitates the option to select anti-cancer drugs suitable for cancer patients without conducting risky tissue biopsy for cancers.
Address: 4-1-28 Toranomon, Minato-ku, Tokyo, 105-0001, JAPAN  (Contact Person Corporate Planning Department)
TEL: +81-3-5472-1578 FAX: +81-3-5472-1488
Web site: https://www.oncolys.com E-mail: oncolys_information@oncolys.com

Onyone Co., Ltd.

Major field:Beauty and Health Care

Miner field:Medical Equipment

Miner field:Other

Manufacturing and sales of sportswear, recovery wear, industrial safety and health supplies, medical devices and etc.

Overview

Manufacturing and sales of clothing and other textile products.
Manufacturing and sales of sportswear and other sports goods.
Manufacturing and sales of medical textile products and medical equipments.
Manufacturing and sales of equipments and supplies for health, nursing care and recovery.
Manufacturing and sales of industrial safety and health supplies and equipments.
Sales of industrial and textile materials, and other materials.

Product / Service / PR

    Onyone was established in July 1968. Since then, Onyone has been manufacturing wide range of clothing such as sportswear and special clothing for extreme cold climate intended for various fields. In 2020, Onyone has acquired the certification of manufacturing and sales of type 3 medical devices, and has been making social contribution in the medial and health fields. In 2021, Onyone will launch the sales of medical devices using A.A.THMedial™ textile in Japan under the brand name of A.A.TH®-ME.
Address: 4327 Takami, Nagaoka, Niigata, Japan  (Contact Person Oki Kobayashi)
TEL: +81-258-24-0048 FAX: +81-258-24-5422
Web site: https://en.onyone.co.jp/ E-mail: eupromotion@onyone.co.jp

OPHTECS CORPORATION

Major field:Production of Drugs and Quasi Drugs

Miner field:Drug Discovery

Production, sales, and export of contact lens solutions and accessories

Optieum Biotechnologies Inc

Major field:Drug Discovery

Orchard Bio Co., Ltd.

Major field:Regenerative Medicine

Miner field:Drug Discovery

Miner field:Contract Research

Development of regenerative medicine product of Cell Holding Active Pharmaceutical ingredient (hAP cells)

Overview

We are developing “Cell Holding Active Pharmaceutical Ingredient” (hAP cells), hybrid regenerative medicine product composing of conventional drugs and human cells. The hAP cells accumulate at the injury sites once administered into the body along the composing cellular intrinsic function and release the encapsulated drug. As the cell effectively function as living DDS in the hAP cell, very small dose of the drugs can be sufficient.

Product / Service / PR

    The hAP cell, hybrid regenerative medicine product composing of conventional drugs and human cells, has tremendous potentials in combination of drugs and cells to apply to various diseases. We are seeking collaborators or partners to facilitate any types of hAP cells. Please contact us if you have any interests.
Address: Gokoudori 8-1-6, Chuou-ku, Koube, Hyogo, Japan, 651-0087  (Contact Person Norio Uematsu)
TEL: 090-9376-1705
Web site: https://orchard-bio.jp/ E-mail: uematsu@orchard-bio.jp

Organization for Small & Medium Enterprises and Regional Innovation, JAPAN

Major field:Assisting Businesses, Rental Laboratories and Offices

Operating Kobe Medical Device Development Center, Kobe Healthcare Industry Development center, etc.

Oriental BioService, Inc.

Major field:Experimental Animals

Miner field:Regenerative Medicine

Miner field:Contract Research

Business in breeding genetically modified animals on consignment